Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

about

Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.Nitinol Self-Expanding Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Three-Year Results of the RELIABLE Japanese Multicenter Study

P2860

Q38377552-798A406B-4F77-4621-828C-40521A6A74EB Q58550954-E1C0B3D7-7FAE-454E-802F-C09B2CFC2DB5

P2860

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

Item

http://www.wikidata.org/entity/Q36411396

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

@ast

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

@en

type

Item

label

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

@ast

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

@en

prefLabel

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

@ast

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

@en

P1476

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

@en

P2093

Jae Seoung Yu

http://www.w3.org/2001/XMLSchema#string

Kee Chun Hong

http://www.w3.org/2001/XMLSchema#string

Keun-Myoung Park

http://www.w3.org/2001/XMLSchema#string

Kyung Rae Kim

http://www.w3.org/2001/XMLSchema#string

Seok-Hwan Shin

http://www.w3.org/2001/XMLSchema#string

Soon Gu Cho

http://www.w3.org/2001/XMLSchema#string

Woo Young Shin

http://www.w3.org/2001/XMLSchema#string

Yong Sun Jeon

http://www.w3.org/2001/XMLSchema#string

Yun-Mee Choe

http://www.w3.org/2001/XMLSchema#string

P2860

Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (Part 1: Above the knee).

Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.

Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis.

The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.

Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures.

Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries.

Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry.

P304

115-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5758/VSI.2015.31.4.115

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26719837

http://www.w3.org/2001/XMLSchema#string

P932

4694182

http://www.w3.org/2001/XMLSchema#string

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

about

P2860

P2860

Midterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932